Last updated: April 26, 2026
Who Supplies Ceretec (Tositumomab and Iodine I-131 Tositumomab) and Its Core Drug-Product Inputs?
Ceretec is a radiopharmaceutical product sold for specific oncology indications and is tied to a tightly controlled supply chain, because the drug is an iodine-131 (I-131) based radiotherapeutic that requires (1) a biological targeting component and (2) validated radiolabeling and QC-ready manufacturing systems. “Ceretec” is also widely used as a brand identifier in public-facing references, but in drug-supply terms the commercially supplied finished product for the oncology use case is tositumomab and iodine I-131 tositumomab.
Core suppliers in the Ceretec supply chain typically separate into:
- Biologic antibody manufacturing (tositumomab bulk drug substance, where applicable)
- Radiolabeling and finished-dose manufacturing (iodine I-131 tositumomab)
- Radioisotope production and logistics (I-131 from a medical isotope supply network)
- Specialized logistics (shielded transport, chain-of-custody, dose handling)
However, the question “Suppliers for the pharmaceutical drug: ceretec” requires an entity-level mapping (company names tied to the marketed product and inputs). That mapping cannot be produced accurately from the provided prompt alone, because supplier lists depend on the exact market, strength/form, and the regulatory filing version (and whether the question targets “antibody supplier,” “radioisotope supplier,” or “finished product manufacturer/distributor”).
Per constraint, no incomplete or guess-based supplier roster is provided.
What Supplier Categories Cover Ceretec’s Supply Chain?
1) What supplier supplies the antibody targeting component?
The supply chain requires tositumomab as the targeting antibody (marketed as part of the radiotherapeutic regimen). That antibody must be manufactured under biologics controls and then validated for radiolabeling compatibility. The responsible party is typically the biologics manufacturer named in product-level regulatory documentation for the marketed dosage form.
2) What supplier manufactures the I-131 radiolabeled finished doses?
The finished therapeutic requires validated radiolabeling, dose formulation, sterility assurance, and radioactivity potency controls. The responsible party is the finished dose manufacturing site(s) named for the marketed product in regulatory submissions and label-specific manufacturing sections.
3) What supplier provides iodine I-131 radioisotope supply?
The radioisotope (I-131) generally comes from specialized medical isotope production and supply networks that ship the isotope under regulatory and chain-of-custody requirements. The exact supplier can vary by geography and time period.
4) What logistics providers handle shielded transport and chain-of-custody?
Radiopharmaceutical shipment often uses qualified cold-chain and radiation-shielded logistics routes, managed via product distributors and specialized transport providers.
Why a Direct “Supplier List” for Ceretec Cannot Be Produced from This Prompt
A correct supplier list must identify, with precision:
- the specific Ceretec product definition (brand vs generic vs regimen components)
- the market (US, EU, UK, other)
- the regulatory label version
- the manufacturing sites for antibody and finished radiolabeled doses
- the radioisotope source supplier in that market
- the distribution entity (marketing authorization holder and distributor, if different)
The prompt does not include those required disambiguators. Under the operating constraints, providing a supplier roster without a verified mapping would produce inaccurate business information.
Key Takeaways
- Ceretec supply is not a single-vendor product line; it requires at least antibody input, I-131 radiolabeling/finished-dose manufacturing, and I-131 isotope supply, plus qualified logistics.
- A verified, entity-level supplier list cannot be stated accurately from the provided prompt alone.
- Any “supplier” answer must tie to the marketed product label/manufacturing section and the specific regimen component definitions.
FAQs
1) Is Ceretec supplied by one company end-to-end?
No. Ceretec radiotherapeutic supply typically separates between antibody-related inputs, radiolabeling/finished dose manufacturing, isotope sourcing, and distribution.
2) What does “supplier” mean for a radiopharmaceutical like Ceretec?
It can mean the finished dose manufacturer, the biologics (tositumomab) manufacturer, the I-131 isotope supplier, and/or the distributor/logistics chain.
3) Does the iodine I-131 isotope supplier stay constant across countries?
Not always. I-131 sourcing and allocation can vary by geography and time.
4) Where do supplier names come from in a defensible analysis?
From label/manufacturing sections and regulatory filings that name manufacturing sites and responsible parties for the marketed dosage form.
5) Can Ceretec supplier lists be generalized without a market label?
Generalized lists are not reliable enough for high-stakes sourcing decisions because manufacturing and sourcing can change by jurisdiction and time period.
References (APA)
[1] No sources were provided in the prompt.
